Kamada (KMDA) Shares Outstanding (2012 - 2026)
Kamada (KMDA) posted quarterly Shares Outstanding (Entity) of $15.1 million for Q1 2026, little changed year-on-year from $15.1 million in Q1 2025, and down 73.86% on a QoQ basis from $57.7 million in Q4 2025.
Kamada (KMDA) Shares Outstanding (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Shares Outstanding (Entity) for 14 consecutive years, with $15.1 million the latest figure, recorded in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.03% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (changed 0.03% YoY) and the FY2025 annual result came in at $57.7 million, changed 0.31% from the prior year.
- Shares Outstanding (Entity) fell to $15.1 million in Q1 2026 per KMDA's latest filing, from $57.7 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for KMDA reached as high as $57.7 million in Q4 2025 and fell as low as $6.7 million in Q2 2024.
- A 5-year average of $27.6 million and a median of $15.1 million in 2025 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 336.86% — and 2023, when it sank 67.58%.
- Year by year, Shares Outstanding (Entity) stood at $44.8 million in 2022, then gained by 28.21% to $57.5 million in 2023, then climbed by 0.04% to $57.5 million in 2024, then grew by 0.31% to $57.7 million in 2025, then tumbled by 73.86% to $15.1 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $15.1 million, $57.7 million, and $15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 57.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.65 Mn |
| Dec 31, 2025 | 57.65 Mn |
| Sep 30, 2025 | 57.49 Mn |
| Jun 30, 2025 | 57.49 Mn |
| Mar 31, 2025 | 57.49 Mn |
| Dec 31, 2024 | 57.49 Mn |
| Sep 30, 2024 | 6.67 Mn |
| Jun 30, 2024 | 6.67 Mn |
| Mar 31, 2024 | 48.83 Mn |
| Dec 31, 2023 | 48.83 Mn |
| Sep 30, 2023 | 44.82 Mn |
| Jun 30, 2023 | 44.82 Mn |
| Mar 31, 2023 | 44.82 Mn |
| Dec 31, 2022 | 44.82 Mn |
| Sep 30, 2022 | 51.20 Mn |
| Jun 30, 2022 | 36.20 Mn |
| Mar 31, 2022 | 44.77 Mn |
| Dec 31, 2021 | 44.77 Mn |
| Sep 30, 2021 | 44.14 Mn |
| Jun 30, 2021 | 44.14 Mn |